IL154167A0 - Methods of drug delivery to hepatocytes and treatment of flaviviridae infections - Google Patents

Methods of drug delivery to hepatocytes and treatment of flaviviridae infections

Info

Publication number
IL154167A0
IL154167A0 IL15416701A IL15416701A IL154167A0 IL 154167 A0 IL154167 A0 IL 154167A0 IL 15416701 A IL15416701 A IL 15416701A IL 15416701 A IL15416701 A IL 15416701A IL 154167 A0 IL154167 A0 IL 154167A0
Authority
IL
Israel
Prior art keywords
hepatocytes
treatment
methods
drug delivery
flaviviridae infections
Prior art date
Application number
IL15416701A
Other languages
English (en)
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of IL154167A0 publication Critical patent/IL154167A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15416701A 2000-08-22 2001-08-21 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections IL154167A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22686900P 2000-08-22 2000-08-22
US24062700P 2000-10-13 2000-10-13
PCT/US2001/026057 WO2002015904A1 (en) 2000-08-22 2001-08-21 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections

Publications (1)

Publication Number Publication Date
IL154167A0 true IL154167A0 (en) 2003-07-31

Family

ID=26920944

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15416701A IL154167A0 (en) 2000-08-22 2001-08-21 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections

Country Status (15)

Country Link
EP (1) EP1313469A1 (cs)
JP (1) JP2004506684A (cs)
KR (1) KR20030040416A (cs)
CN (1) CN1447692A (cs)
AU (1) AU2001292557A1 (cs)
BR (1) BR0113388A (cs)
CA (1) CA2415793A1 (cs)
CZ (1) CZ2003308A3 (cs)
HU (1) HUP0302884A2 (cs)
IL (1) IL154167A0 (cs)
MX (1) MXPA03001529A (cs)
NO (1) NO20030794L (cs)
PL (1) PL365744A1 (cs)
RU (1) RU2003102607A (cs)
WO (1) WO2002015904A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037908A1 (en) * 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) * 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5959077A (en) * 1993-05-26 1999-09-28 Laboratori Balducci S.P.A. Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CZ2003308A3 (cs) 2004-03-17
RU2003102607A (ru) 2004-07-27
HUP0302884A2 (hu) 2003-12-29
MXPA03001529A (es) 2004-04-02
BR0113388A (pt) 2004-02-25
EP1313469A1 (en) 2003-05-28
WO2002015904B1 (en) 2002-07-04
NO20030794L (no) 2003-04-22
NO20030794D0 (no) 2003-02-20
AU2001292557A1 (en) 2002-03-04
CN1447692A (zh) 2003-10-08
WO2002015904A1 (en) 2002-02-28
CA2415793A1 (en) 2002-02-28
JP2004506684A (ja) 2004-03-04
PL365744A1 (en) 2005-01-10
KR20030040416A (ko) 2003-05-22

Similar Documents

Publication Publication Date Title
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
PL372925A1 (en) Prevention and treatment of restenosis by local administration of drug
HUP0500003A3 (en) Improvements in and relating to medicament injection apparatus
IL215891A (en) Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections
GB2412318B (en) Drug delivery particles and methods of treating particles to improve their drug delivery capabilities
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
DK1183029T3 (da) Farmaceutisk præparat indeholdende diamorfin og vitamin E og dets anvendelse til behandling af opiatmisbrug
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
AU6118001A (en) Combination therapeutic compositions and methods of use
AU2002347575A1 (en) Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
AU3898700A (en) Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
IL160754A0 (en) Dosage form, device and methods of treatment
HUP0301892A3 (en) Pharmaceutical compositions for treatment of sexual dysfunction and their preparation
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
IL154167A0 (en) Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
EP1356812A4 (en) DRUGS FOR TREATING AND PREVENTING NEUROLOGICAL PAIN
GB9912639D0 (en) Improvements in and relating to treatment of respiratory conditions
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HK1053976A (en) Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
GB0003201D0 (en) Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
IL155819A0 (en) Methods of treatment comprising administration of substance p
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
HUP0301119A3 (en) Biologically active agent and drug
GB0007788D0 (en) Method to evaluate the therapeutic and toxic effects related to drug administration
AU2002322424A8 (en) Novel methods and formulations for administration of active agents